Bleichroeder Acquisition Corp. II 8-K

What Happened
Bleichroeder Acquisition Corp. II (Parent or Bleichroeder) filed an 8‑K on May 26, 2026 announcing Amendment No. 1 to its Agreement and Plan of Merger with Pasqal Holding SAS (the Business Combination). The amendment (and related assignment agreements) substitutes a new French merger subsidiary (Bleichroeder Acquisition France Merger Sub 2) in place of the original Parent Merger Sub, updates the transaction structure and related provisions to reflect contemplated reincorporation/merger mechanics, and addresses related financing arrangements. Separately, on May 23, 2026 the parties amended the Securities Purchase Agreement (SPA) to increase the subscription to $250.0 million and to add an accredited investor advised by Inflection Point as a purchaser. Bleichroeder and Pasqal also issued a joint press release and Parent Merger Sub filed a Form F‑4 registration statement with the SEC in connection with the transaction.

Key Details

• Amendment date (Merger): May 26, 2026; SPA amendment date: May 23, 2026.
• SPA increase: subscription price raised by $50.0 million to $250.0 million (to purchase $312,500,000 aggregate principal amount of Senior Unsecured Convertible Bonds and related Investment Warrants).
• Assignment: Parent Merger Sub assigned its rights under the Merger Agreement to New Merger Sub (Bleichroeder Acquisition France Merger Sub 2); New Merger Sub assumed those rights and obligations; Parent Merger Sub is released from post‑assignment obligations (except liabilities that arose prior to assignment).
• Regulatory filing: Parent Merger Sub publicly filed a Form F‑4 registration statement; a definitive proxy/prospectus will be mailed after effectiveness.

Why It Matters
The amendment and SPA changes are material to investors because they (1) adjust the merger structure by substituting a new merger subsidiary and updating legal/authorization terms, and (2) increase committed financing for the combined company from the SPA participants to $250M, which affects the cash and capital structure expected to support the proposed business combination with Pasqal. The Form F‑4 filing starts the formal disclosure process to shareholders; investors should review the registration statement and the eventual proxy/prospectus for full terms, risks and voting information before making any investment or voting decision.